S

San Antonio Eye Center | Northwest (Ingram Park)

Research site

(Unclaimed)

Location

6151 Northwest Loop 410, Suite 200, San Antonio, Texas, United States of America

Site insights

Top conditions

Top treatments

Bimatoprost

Timolol Maleate

DE-126

OT-101

Triamcinolone Acetonide

Netarsudil

JNJ-81201887

Latanoprost

TC-002

Abicipar Pegol

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 18 total trials

A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

The purpose of this study is to evaluate change in geographic atrophy (GA) lesion growth of eyes treated with JNJ-81201887 compared to sham control.

Enrolling

Geographic Atrophy

Drug: Triamcinolone

Other: Sham Procedure

Long-term Safety and Efficacy Extension Trial of Bimatoprost SR (Maia)

This study will evaluate the long-term safety and efficacy of Bimatoprost Sustained Release (SR) in patients with open-angle glaucoma or ocular hyper...

Invitation-only

Open-Angle Glaucoma

Ocular Hypertension

Drug: Bimatoprost SR

Other: Standard of Care

Prospective, Double-masked, Randomized, Multi-center, Active-controlled, Parallel-group, 3-month Study Assessing the Safety & Ocular Hypotensive Efficacy of TC-002 Ophthalmic Solution Compared to Latanoprost Ophthalmic Solution 0.005% in Subjects With Elevated Intraocular Pressure (TC-002-301)

Prospective, double-masked, randomized, multi-center, active-controlled, parallel-group, 3-month study assessing the safety and ocular hypotensive ef...

Active, not recruiting

Elevated Intraocular Pressure

Drug: TC-002 latanoprost ophthalmic solution, 0.005%

Drug: Latanoprost ophthalmic solution, 0.005%

Study of OT-101 in Treating Myopia

This is a phase III, randomized, double-masked, placebo-controlled, parallel-group, multicenter safety, tolerability, and efficacy study of atropine...

Active, not recruiting

Myopia, Progressive

Drug: OT-101 Ophthalmic Solution

Drug: Vehicle